Long-term outcomes of two-dose alemtuzumab induction in pediatric kidney transplantation.
Rachel M EngenSharon M BartoshPublished in: Pediatric transplantation (2024)
A two-dose alemtuzumab induction protocol can have excellent outcomes with a steroid-free maintenance immunosuppression regimen. More comprehensive, multicenter, comparative studies of pediatric kidney transplant are needed to improve long-term outcomes.